167
Participants
Start Date
September 30, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
EFV/FTC/TDF
FDC efavirenz/emtricitabine/tenofovir disoproxil fumarate (Atripla) 600 mg/200 mg/ 300 mg tablet taken orally once daily at bedtime on an empty stomach.
Calcium Carbonate
Calcium carbonate 500 mg tablet taken orally twice daily with food for 48 weeks.
Vitamin D3
One Vitamin D3 4000 IU capsule taken orally once daily with food for 48 weeks.
Placebo for calcium carbonate
A placebo for calcium carbonate twice daily taken orally as one x 0 mg tablets with food for 48 weeks
Placebo for vitamin D3
A placebo for vitamin D3 once daily taken orally as one capsule with food for 48 weeks.
Cornell CRS (7804), New York
NY Univ. HIV/AIDS CRS (401), New York
HIV Prevention & Treatment CRS (30329), New York
Bronx-Lebanon Hosp. Ctr. CRS (31469), The Bronx
AIDS Care CRS (1108), Rochester
University of Rochester ACTG CRS (1101), Rochester
Pittsburgh CRS (1001), Pittsburgh
Hosp. of the Univ. of Pennsylvania CRS (6201), Philadelphia
Georgetown University CRS (GU CRS) (1008), Washington D.C.
IHV Baltimore Treatment CRS (4651), Baltimore
Regional Center for Infectious Disease, Wendover Medical Center CRS (3203), Greensboro
Unc Aids Crs (3201), Chapel Hill
Duke University Medical Center Adult CRS (1601), Durham
The Ponce de Leon Ctr. CRS (5802), Atlanta
Alabama Therapeutics CRS (5801), Birmingham
Vanderbilt Therapeutics CRS (3652), Nashville
The Ohio State Univ. AIDS CRS (2301), Columbus
Case CRS (2501), Cleveland
MetroHealth CRS (2503), Cleveland
Univ. of Cincinnati CRS (2401), Cincinnati
Northwestern University CRS (2701), Chicago
Rush University Medical Center (2702), Chicago
Washington University CRS (2101), St Louis
Trinity Health and Wellness Center CRS (31443), Dallas
Houston AIDS Research Team CRS (31473), Houston
University of Colorado Hospital CRS (6101), Aurora
Usc Crs (1201), Los Angeles
UCLA CARE Center CRS (601), Los Angeles
Harbor-UCLA Med. Ctr. CRS (603), Torrance
Ucsd, Avrc Crs (701), San Diego
Ucsf Aids Crs (801), San Francisco
Stanford CRS (501), Palo Alto
University of Washington AIDS CRS (1401), Seattle
Massachusetts General Hospital ACTG CRS (101), Boston
Brigham and Women's Hosp. ACTG CRS (107), Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS (103), Boston
New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477), Newark
The Miriam Hosp. ACTG CRS (2951), Providence
Puerto Rico-AIDS CRS (5401), San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK